| scholarly article | Q13442814 |
| P2093 | author name string | Yan Wang | |
| Jun Xu | |||
| Bo Xu | |||
| Ling Wang | |||
| Yan Yuan | |||
| Lorenzo González-Molleda | |||
| P2860 | cites work | Aids-related malignancies | Q22251046 |
| Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold | Q24556499 | ||
| (+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice | Q27677636 | ||
| Comparison of multiple Amber force fields and development of improved protein backbone parameters | Q27861040 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection | Q28299060 | ||
| Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models | Q29616389 | ||
| Mechanism of 150-cavity formation in influenza neuraminidase | Q30404742 | ||
| A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus | Q33559699 | ||
| Selecting diversified compounds to build a tangible library for biological and biochemical assays. | Q33639925 | ||
| The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases | Q33644236 | ||
| Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression | Q33653424 | ||
| Kaposi's Sarcoma-Associated Herpesvirus Lytic Origin ( ori-Lyt )-Dependent DNA Replication: Identification of the ori-Lyt and Association of K8 bZip Protein with the Origin | Q34976942 | ||
| The immune reconstitution inflammatory syndrome | Q35183366 | ||
| Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: dual role of replication and transcription activator | Q35185944 | ||
| Potent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirus | Q35689364 | ||
| Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: involvement of host cellular factors | Q36484112 | ||
| Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription | Q36684599 | ||
| Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study | Q36800955 | ||
| HIV-associated Kaposi sarcoma: pathogenesis and therapy | Q36974970 | ||
| Mechanism of glycan receptor recognition and specificity switch for avian, swine, and human adapted influenza virus hemagglutinins: a molecular dynamics perspective | Q37434500 | ||
| Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma | Q37535731 | ||
| Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma | Q38888677 | ||
| A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma | Q39435212 | ||
| N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase | Q39530047 | ||
| A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant | Q39539612 | ||
| Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
| Bioactive coumarins from Boenninghausenia sessilicarpa | Q40158092 | ||
| Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. | Q40364647 | ||
| Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. | Q40433154 | ||
| Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results | Q41085746 | ||
| Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture | Q41225141 | ||
| Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia? | Q41984354 | ||
| Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform | Q42606268 | ||
| The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease. | Q43927346 | ||
| Human small cell lung cancer NYH cells resistant to the bisdioxopiperazine ICRF-187 exhibit a functional dominant Tyr165Ser mutation in the Walker A ATP binding site of topoisomerase II alpha. | Q44014803 | ||
| Nucleotide-dependent domain movement in the ATPase domain of a human type IIA DNA topoisomerase. | Q46650258 | ||
| LOOPER: a molecular mechanics-based algorithm for protein loop prediction | Q46808318 | ||
| Enhancing molecular shape comparison by weighted Gaussian functions | Q48025987 | ||
| Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. | Q50999171 | ||
| GB/SA water model for the Merck molecular force field (MMFF). | Q52072964 | ||
| Kaposi's Sarcoma | Q54197804 | ||
| A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity. | Q54303655 | ||
| Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma | Q58004179 | ||
| KSHV: forgotten but not gone | Q58481160 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 563-573 | |
| P577 | publication date | 2013-12-02 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Antiviral activity of (+)-rutamarin against Kaposi's sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II. | |
| P478 | volume | 58 |
| Q48299334 | Discovering new PI3Kα inhibitors with a strategy of combining ligand-based and structure-based virtual screening. |
| Q36432654 | Discovering new mTOR inhibitors for cancer treatment through virtual screening methods and in vitro assays |
| Q38271135 | KSHV targeted therapy: an update on inhibitors of viral lytic replication |
| Q28551996 | Phosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic Signaling |
| Q38694918 | Rutamarin, an Active Constituent from Ruta angustifolia Pers., Induced Apoptotic Cell Death in the HT29 Colon Adenocarcinoma Cell Line |
| Q38916328 | Therapeutic potential of coumarins as antiviral agents |
Search more.